The committee of board of Sun Pharma Advanced Research Company has approved the allotment of about 6.25 crore warrants on preferential basis at ₹178 each (₹44.50/warrant as subscription price and ₹133.50/warrant as exercise price) to Dilip Shantilal Shanghvi, promoter of the company, and to certain other non-promoter persons/entities. The company has raised ₹1,112.04 crore through warrants. As against the earlier approval for issue of about 6.75 crore warrants, the committee has allotted only about 6.25 crore warrants, due to non-receipt of subscription money by the proposed allottees and/or non- receipt of in-principle approval from the exchanges, it said.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.